Director/PDMR Shareholding

Dr Martens

17/06/2025 10:00

RNS Number : 1781N

Dr. Martens PLC

17 June 2025

 

Dr. Martens plc (the 'Company')

Director / PDMR Shareholding

Notification of Transactions by Directors / Persons Discharging Managerial Responsibility

The Company announces that on 16 June 2025 the following directors / persons discharging managerial responsibility ('PDMR') were granted Performance Share Awards (the 'Awards') under the Company's Long Term Incentive Plan (the 'LTIP').

 

PDMR
Number of Shares
Ije Nwokorie
2,628,032
Giles Wilson
2,019,743

 

As disclosed in the Company's 2025 Annual Report, the Awards will vest subject to the achievement of three equally weighted targets, namely cumulative earnings per share, relative total shareholder return and operating cash flow conversion, over three years. On vesting, the Awards will be subject to a further two-year holding period. No consideration was paid for the grant of the Award and no price is payable on the exercise of the Award.

Full details of the target ranges are set out in the Directors' Remuneration Report contained within the 2025 Annual Report & Accounts, which is available on the Company's website at www.drmartensplc.com.

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

 

1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Ije Nwokorie
2
Reason for the notification
a)
Position/status
PDMR (Chief Executive Officer)
b)
Initial notification/Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Dr. Martens plc
b)
LEI
213800QPT8YM6NQZPH28
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of GBP 0.01

 ISIN: GB00BL6NGV24
b)
Nature of the transaction
Grant of performance share award under the Dr. Martens Long Term Incentive Plan
c)
Price(s) and volume(s)
Price(s)
Volume(s)
Nil
2,628,032
d)
Aggregated information
-
Aggregated volume
-
Price
2,628,032
Nil
e)
Date of the transaction
16 June 2025
f)
Place of the transaction
Outside of a trading venue

 

 

1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Giles Wilson
2
Reason for the notification
a)
Position/status
PDMR (Chief Financial Officer)
b)
Initial notification/Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Dr. Martens plc
b)
LEI
213800QPT8YM6NQZPH28
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of GBP 0.01

 ISIN: GB00BL6NGV24
b)
Nature of the transaction
Grant of performance share award under the Dr. Martens Long Term Incentive Plan
c)
Price(s) and volume(s)
Price(s)
Volume(s)
Nil
2,019,743
d)
Aggregated information
-
Aggregated volume
-
Price
2,019,743
Nil
e)
Date of the transaction
16 June 2025
f)
Place of the transaction
Outside of a trading venue

 

For further information, please contact:

Paul Rolling, Head of Secretariat

+447584243562

Bethany Barnes, Director of Investor Relations

+447825187465

ENDS

About Dr. Martens

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. "Docs" or "DMs" were originally produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history. It operates in over 60 countries and employs over 3,650 people worldwide. Its operations are split across both Direct-to-Consumer and wholesale channels, and in addition to its world-renowned "1460" boot its product segments span shoes including the 1461 shoe and Adrian loafer, sandals including the Zebzag mule, Kids ranges, as well as a growing line of bags and accessories. Further information can be found at https://www.drmartensplc.com/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHUBVWRVVUNARR